GlassScriptPhysician profile
Jeffrey N Alter
NPI 1023015542
$3,038.47
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,512 · 2020: $364 · 2021: $1,134 · 2022: $29.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $680.46 | 2019-2021 | |
| Pfizer INC. | $367.77 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $210.97 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $208.28 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $177.66 | 2019-2021 | |
| Leo Pharma INC. | $175.23 | 2019-2021 | |
| Genzyme Corporation | $173.92 | 2019-2021 | |
| Ucb, INC. | $162.50 | 2019-2021 | |
| Celgene Corporation | $128.81 | 2019 | |
| Janssen Biotech, INC. | $98.89 | 2019-2021 | |
| Prugen, INC. Pharmaceuticals | $93.03 | 2019-2020 | |
| Lilly USA, LLC | $89.46 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $87.64 | 2019-2021 | |
| Amgen INC. | $76.66 | 2019-2021 | |
| Genentech USA, INC. | $59.21 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $58.50 | 2019-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $52.13 | 2021 | |
| Mayne Pharma Commercial LLC | $39.20 | 2019 | |
| Epi Health, LLC | $25.79 | 2021 | |
| Encore Dermatology INC. | $19.97 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $17.63 | 2019 | |
| Promius Pharma LLC | $17.62 | 2019 | |
| Incyte Corporation | $17.14 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Alter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.